Drug Research

AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentacles™...

Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR). The standard was facilitated by BSI...

Big Pharma goes on to drive the demand for contract resource organizations- CROs by way of outsourcing almost 45% of research and development activities. It is well to be noted that the global biotechnology as well as pharmaceutical services...

Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery...

The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an average of $2.6 billion. The AI as well as computing revolutions, however, happen to be...

The global cancer diagnostics market, valued at USD 163.7 billion in 2021, is anticipated to witness substantial growth, reaching over USD 335.7 billion by 2031, with a projected compound annual growth rate (CAGR) of 7.4% from 2022 to 2031. Analysts...

The painstaking journey to bring one new drug to market almost spans a decade and costs an average of $2.6 billion. The AI as well as computing revolution, however, happens to be dynamically shifting the pharma industry, getting into...